Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders
Indications for using standard anticoagulants, heparin and warfarin; the dosage and route of administration; the importance of monitoring therapy with reliable laboratory indices; and complications of therapy are discussed. Acetylsalicylic acid and ticlopidine can be used as antiplatelet agents. Bec...
Gespeichert in:
| Veröffentlicht in: | Canadian family physician 1993-02, Vol.39, p.290-304 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 304 |
|---|---|
| container_issue | |
| container_start_page | 290 |
| container_title | Canadian family physician |
| container_volume | 39 |
| creator | Anderson, D R Fernandez, L A |
| description | Indications for using standard anticoagulants, heparin and warfarin; the dosage and route of administration; the importance of monitoring therapy with reliable laboratory indices; and complications of therapy are discussed. Acetylsalicylic acid and ticlopidine can be used as antiplatelet agents. Because their effect on platelet function is not monitored clinically, their clinical indications are emphasized. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2379733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>451950711</sourcerecordid><originalsourceid>FETCH-LOGICAL-p288t-98365a1a5c46b98129a48c75b67cc69c8e30da6030211c1ffc523f9d2d2c8af73</originalsourceid><addsrcrecordid>eNpVkEtLxDAUhYMo4zj6E4TgvpJHkyYbQQZfMOJGwV25TdJOhk5T01SZf2_VQXR1X4fvHO4BmtOCikwwoQ7RnBCiMi7I6zE6GYYNIUzmnM7QTOVaUEbmyC5Dl2JocagxdMmbAM3YTt002e9N30JyrUs4rV2EfneJH6GDxncN7iF516UBf_i0xmDG5CZVDNsqTCRs_RCidXE4RUc1tIM729cFerm9eV7eZ6unu4fl9SrrmVIp04pLARSEyWWlFWUacmUKUcnCGKmNcpxYkIQTRqmhdW0E47W2zDKjoC74Al39cPux2jprpmwR2rKPfgtxVwbw5f9L59dlE95LxgtdcD4BLvaAGN5GN6RyE8bYTZlLRgSVQuov0flfl1_8_qf8EzGldsE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205165693</pqid></control><display><type>article</type><title>Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Anderson, D R ; Fernandez, L A</creator><creatorcontrib>Anderson, D R ; Fernandez, L A</creatorcontrib><description>Indications for using standard anticoagulants, heparin and warfarin; the dosage and route of administration; the importance of monitoring therapy with reliable laboratory indices; and complications of therapy are discussed. Acetylsalicylic acid and ticlopidine can be used as antiplatelet agents. Because their effect on platelet function is not monitored clinically, their clinical indications are emphasized.</description><identifier>ISSN: 0008-350X</identifier><identifier>EISSN: 1715-5258</identifier><identifier>PMID: 8495120</identifier><language>eng</language><publisher>Canada: College of Family Physicians of Canada</publisher><subject>Administration, Oral ; Anticoagulants - adverse effects ; Anticoagulants - blood ; Anticoagulants - therapeutic use ; Bleeding Time ; Drug Administration Schedule ; Drug Interactions ; Drug Monitoring - methods ; Family Practice - methods ; Heart disease ; Humans ; Infusions, Intravenous ; Injections, Intravenous ; Injections, Subcutaneous ; Partial Thromboplastin Time ; Prothrombin Time ; Thrombosis ; Thrombosis - blood ; Thrombosis - drug therapy</subject><ispartof>Canadian family physician, 1993-02, Vol.39, p.290-304</ispartof><rights>Copyright College of Family Physicians of Canada Feb 1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2379733/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2379733/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8495120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anderson, D R</creatorcontrib><creatorcontrib>Fernandez, L A</creatorcontrib><title>Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders</title><title>Canadian family physician</title><addtitle>Can Fam Physician</addtitle><description>Indications for using standard anticoagulants, heparin and warfarin; the dosage and route of administration; the importance of monitoring therapy with reliable laboratory indices; and complications of therapy are discussed. Acetylsalicylic acid and ticlopidine can be used as antiplatelet agents. Because their effect on platelet function is not monitored clinically, their clinical indications are emphasized.</description><subject>Administration, Oral</subject><subject>Anticoagulants - adverse effects</subject><subject>Anticoagulants - blood</subject><subject>Anticoagulants - therapeutic use</subject><subject>Bleeding Time</subject><subject>Drug Administration Schedule</subject><subject>Drug Interactions</subject><subject>Drug Monitoring - methods</subject><subject>Family Practice - methods</subject><subject>Heart disease</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Injections, Intravenous</subject><subject>Injections, Subcutaneous</subject><subject>Partial Thromboplastin Time</subject><subject>Prothrombin Time</subject><subject>Thrombosis</subject><subject>Thrombosis - blood</subject><subject>Thrombosis - drug therapy</subject><issn>0008-350X</issn><issn>1715-5258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLxDAUhYMo4zj6E4TgvpJHkyYbQQZfMOJGwV25TdJOhk5T01SZf2_VQXR1X4fvHO4BmtOCikwwoQ7RnBCiMi7I6zE6GYYNIUzmnM7QTOVaUEbmyC5Dl2JocagxdMmbAM3YTt002e9N30JyrUs4rV2EfneJH6GDxncN7iF516UBf_i0xmDG5CZVDNsqTCRs_RCidXE4RUc1tIM729cFerm9eV7eZ6unu4fl9SrrmVIp04pLARSEyWWlFWUacmUKUcnCGKmNcpxYkIQTRqmhdW0E47W2zDKjoC74Al39cPux2jprpmwR2rKPfgtxVwbw5f9L59dlE95LxgtdcD4BLvaAGN5GN6RyE8bYTZlLRgSVQuov0flfl1_8_qf8EzGldsE</recordid><startdate>19930201</startdate><enddate>19930201</enddate><creator>Anderson, D R</creator><creator>Fernandez, L A</creator><general>College of Family Physicians of Canada</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>19930201</creationdate><title>Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders</title><author>Anderson, D R ; Fernandez, L A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p288t-98365a1a5c46b98129a48c75b67cc69c8e30da6030211c1ffc523f9d2d2c8af73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Administration, Oral</topic><topic>Anticoagulants - adverse effects</topic><topic>Anticoagulants - blood</topic><topic>Anticoagulants - therapeutic use</topic><topic>Bleeding Time</topic><topic>Drug Administration Schedule</topic><topic>Drug Interactions</topic><topic>Drug Monitoring - methods</topic><topic>Family Practice - methods</topic><topic>Heart disease</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Injections, Intravenous</topic><topic>Injections, Subcutaneous</topic><topic>Partial Thromboplastin Time</topic><topic>Prothrombin Time</topic><topic>Thrombosis</topic><topic>Thrombosis - blood</topic><topic>Thrombosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, D R</creatorcontrib><creatorcontrib>Fernandez, L A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, D R</au><au>Fernandez, L A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders</atitle><jtitle>Canadian family physician</jtitle><addtitle>Can Fam Physician</addtitle><date>1993-02-01</date><risdate>1993</risdate><volume>39</volume><spage>290</spage><epage>304</epage><pages>290-304</pages><issn>0008-350X</issn><eissn>1715-5258</eissn><abstract>Indications for using standard anticoagulants, heparin and warfarin; the dosage and route of administration; the importance of monitoring therapy with reliable laboratory indices; and complications of therapy are discussed. Acetylsalicylic acid and ticlopidine can be used as antiplatelet agents. Because their effect on platelet function is not monitored clinically, their clinical indications are emphasized.</abstract><cop>Canada</cop><pub>College of Family Physicians of Canada</pub><pmid>8495120</pmid><tpages>15</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-350X |
| ispartof | Canadian family physician, 1993-02, Vol.39, p.290-304 |
| issn | 0008-350X 1715-5258 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2379733 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Administration, Oral Anticoagulants - adverse effects Anticoagulants - blood Anticoagulants - therapeutic use Bleeding Time Drug Administration Schedule Drug Interactions Drug Monitoring - methods Family Practice - methods Heart disease Humans Infusions, Intravenous Injections, Intravenous Injections, Subcutaneous Partial Thromboplastin Time Prothrombin Time Thrombosis Thrombosis - blood Thrombosis - drug therapy |
| title | Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A57%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20anticoagulant%20and%20antiplatelet%20therapy.%20Managing%20patients%20with%20acute%20thrombotic%20disorders&rft.jtitle=Canadian%20family%20physician&rft.au=Anderson,%20D%20R&rft.date=1993-02-01&rft.volume=39&rft.spage=290&rft.epage=304&rft.pages=290-304&rft.issn=0008-350X&rft.eissn=1715-5258&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E451950711%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205165693&rft_id=info:pmid/8495120&rfr_iscdi=true |